This new street drug is 10,000 times more potent than morphine, and now it\u2019s showing up in Canada and the U.S.<\/p>\n
It was first developed in a Canadian lab more than three decades ago, promising and potent \u2014 and intended to relieve pain in a less addictive way. Labeled W-18, the synthetic opioid was the most powerful in a series of about 30 compounds concocted at the University of Alberta and patented in the U.S. and Canada in 1984.<\/p>\n
But no pharmaceutical company would pick it up, so on a shelf the recipe sat, the research chronicled in medical journals but never put to use. The compound was largely forgotten.\u00a0 Then a Chinese chemist found it, and in labs halfway around the world started developing the drug for consumers in search of a cheap and legal high \u2014 one experts say is 100 times more potent than fentanyl and 10,000 stronger than morphine. [Deaths from opioid overdoses set a record in 2014]<\/p>\n
And now it has come to North America. The substance first surfaced in Canada last fall, when Calgary police seized pills containing traces of the drug,according to the Calgary Herald. Then more than 2.5 pounds of W-18 was discovered in the home of a Florida man, who was sentenced to 10 years in federal prison after he pleaded guilty to smuggling fentanyl from China,reported the Sun Sentinel. He faced no charges for possessing the W-18, however, because it\u2019s not yet illegal in the U.S.<\/p>\n
And just last week, Health Canada\u2019s Drug Analysis Service confirmed that four kilograms of a chemical powder seized in a fentanyl investigation in December 2015 was indeed the dangerous W-18 drug. Health officials are concerned for many reasons. There are currently no tests to detect the drug in a person\u2019s blood or urine, according to reports, making it difficult for doctors to help someone who might be overdosing, a risk outlined in the drug\u2019s 1984 patent.\u00a0 Its effect on humans is largely unknown because W-18 was only ever tested on lab mice.<\/p>\n
\u201cWhenever this drug starts circulating on the streets you\u2019re going to have deaths,\u201d Sacramento-based forensic chemist Brian Escamilla told the Calgary Sun. Health Canada is working to have W-18 added to its Controlled Drugs and Substances Act.<\/p>\n
The Drug Enforcement Administration has not made a formal statement warning of the hazards of W-18, but a spokesman for the department did tell the Calgary Sun that its unclear how far the drug has infiltrated the U.S. and alluded to reports suggesting W-18 is being cut with heroin and cocaine in Philadelphia.\u00a0 If that\u2019s true, the new drug could exacerbate the growing heroin epidemic.<\/p>\n
The debut of W-18 also draws attention to the growing influence Chinese chemists have on the kinds of drugs entering the U.S. Last fall, China banned 116 different synthetic drugs, according to reports, including fentanyl and the deadly flakka, a drug that put south Florida in crisis mode. Since then, flakka has all but disappeared.<\/p>\n
In its absence, however, Chinese drug manufacturers began producing alternatives to sell, including W-18, a DEA spokesman told the Calgary Sun.<\/p>\n
\u201cInstead of selling heroin in quarter-ounce, half-ounce quantities, you\u2019re talking about micrograms of these substances that are 100 times more potent than fentanyl,\u201d Baer said.<\/p>\n
Source:\u00a0 https:\/\/www.washingtonpost.com\/news\/morning-mix\/wp\/2016\/04\/27<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" This new street drug is 10,000 times more potent than morphine, and now it\u2019s showing up in Canada and the U.S. It was first developed in a Canadian lab more than three decades ago, promising and potent \u2014 and intended to relieve pain in a less addictive way. Labeled W-18, the synthetic opioid was the […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-11557","post","type-post","status-publish","format-standard","hentry","category-drug-specifics"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/11557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=11557"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/11557\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=11557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=11557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=11557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}